BIO 2026: US needs to dodge China’s ‘inescapable dependencies’ to protect biotech
Source: news.google.com
Published: Jun 24, 2026 11:23
Source: news.google.com
Published: Jun 24, 2026 11:23
Related Stories
VS-7375 Demonstrates Clinical Activity with a Favorable Safety and Tolerability Profile in TARGET-D 101 Phase 1/2 Clinical Trial in Patients with Advanced KRAS G12D-Mutated Solid Tumors BioSpace
#Clinical TrialsJavelin Biotech and Pfizer Announce Landmark Publication Demonstrating Clinical PK Predictions Using Multi-Tissue Chip Platform BioSpace
#Biotech HeadlinesBiotech Visionary Is Skeptical About AI’s Impact on Medical Innovation Bloomberg.com
#Health InnovationOphthalmology venture grabs investors’ attention, raises $330 million statnews.com
#Biotech HeadlinesRQ Bio raises $115 million for long-acting flu antibody The Pharmaletter
#Biotech HeadlinesFDA gives CalciMedica no comments on Auxora safety review Stock Titan
#Clinical TrialsAdd Shortcut
Open this site faster like an app from your phone home screen.